Cord blood transplantation using tacrolimus and MMF as GVHD prophylaxis
Not Applicable
- Conditions
- AML, ALL, CML, MDS, ML, AT
- Registration Number
- JPRN-UMIN000006339
- Lead Sponsor
- Fukuoka BMT group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
Not provided
Exclusion Criteria
1.not sensitive to chemotherapy 2.complicated infection 3.positive for HBV,HCV,HIV 4.double cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse effects more than grade3 within 100 days after CBT
- Secondary Outcome Measures
Name Time Method